Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.

Saved in:
Bibliographic Details
Title: Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.
Authors: Wu A; Department of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Anderson H; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Hughesman C; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Young S; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Lohrisch C; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Ross CJD; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Carleton BC; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; Therapeutic Evaluation Unit, Provincial Health Services Authority, Vancouver, BC, Canada.
Source: Frontiers in pharmacology [Front Pharmacol] 2023 Sep 08; Vol. 14, pp. 1257745. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37745065
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wu+A%22">Wu A</searchLink>; Department of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Anderson+H%22">Anderson H</searchLink>; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Hughesman+C%22">Hughesman C</searchLink>; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Young+S%22">Young S</searchLink>; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Lohrisch+C%22">Lohrisch C</searchLink>; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ross+CJD%22">Ross CJD</searchLink>; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Carleton+BC%22">Carleton BC</searchLink>; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; Therapeutic Evaluation Unit, Provincial Health Services Authority, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2023 Sep 08; Vol. 14, pp. 1257745. <i>Date of Electronic Publication: </i>2023 Sep 08 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37745065
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2023.1257745
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1257745
    Titles:
      – TitleFull: Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu A
      – PersonEntity:
          Name:
            NameFull: Anderson H
      – PersonEntity:
          Name:
            NameFull: Hughesman C
      – PersonEntity:
          Name:
            NameFull: Young S
      – PersonEntity:
          Name:
            NameFull: Lohrisch C
      – PersonEntity:
          Name:
            NameFull: Ross CJD
      – PersonEntity:
          Name:
            NameFull: Carleton BC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 09
              Text: 2023 Sep 08
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1